Lactate-Driven Histone Lactylation Weakens B Cell Immunity in Tertiary Lymphoid Structures
DOI:
https://doi.org/10.63808/irc.v2i1.539Keywords:
Tertiary lymphoid structures, Histone lactylation, B cell immunity, Tumor microenvironment, Immune metabolismAbstract
The function of tertiary lymphoid structures (TLS), which are important locations in the tumour microenvironment that promote anti-tumor humoral immunity, is frequently depleted in advanced tumours, and the underlying mechanisms are yet unknown. Through histone lactylation, the tumour metabolite lactate modifies the epigenetic status of B cells in TLS, thereby compromising their immunological activity. We used single-cell RNA sequencing, chromatin accessibility studies, and microscopic dissection of mature TLS from clinical non-small cell lung cancer tissues and animal tumour models. Lactate concentrations within TLS were determined using targeted quantitative metabolomics, and the genome-wide H3K18 lactylation signature in B cells was mapped using CUT&Tag technology. The functional impact of histone lactylation on B cell antibody generation and anti-tumor efficacy was assessed utilising adoptive transfer procedures, B cell receptor lineage tracing, and immunofluorescence in a mouse model with B cell-specific deletion of lactate dehydrogenase A. High lactate concentrations in the tumour microenvironment cause TLS-B cells to abnormally concentrate H3K18 lactylation in immunoglobulin class switch recombination sites and promoters of genes linked to somatic hypermutation. IgG2b/c class switching and affinity maturation are prevented by this epigenetic remodelling, which directly reduces the production of activation-induced cytidine deaminase and essential transcription factors. According to functional studies, mature germinal center responses in TLS can be restored by suppressing lactylation reading proteins or preventing lactate metabolism in B cells. This greatly improves antibody-dependent tumour killing and reverses resistance to immune checkpoint blockade therapy. The “lactate-histone lactylation” axis is identified in this study as a novel metabolic checkpoint for B cell immunity within TLS. This discovery reveals a pathogenic pathway by which the immunosuppressive microenvironment takes control of humoral immunity at the epigenetic level and offers specific targets for the development of combination immunotherapies aimed at restoring TLS functionality.
References
[1] Angelin, A., Gil-de-Gómez, L., Dahiya, S., et al. (2017). Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab, 25(6), 1282-1293.e7. https://doi.org/10.1016/j.cmet.2016.12.018
[2] Bolland, D. J., Koohy, H., Wood, A. L., Matheson, L. S., Krueger, F., Stubbington, M. J., Baizan-Edge, A., Chovanec, P., Stubbs, B. A., Tabbada, K., Andrews, S. R., Spivakov, M., & Corcoran, A. E. (2016). Two mutually exclusive local chromatin states drive efficient V(D)J recombination. Cell Rep, 15(11), 2475-2487. https://doi.org/10.1016/j.celrep.2016.05.020
[3] Brand, A., Singer, K., Koehl, G. E., et al. (2016). LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab, 24(5), 657-671. https://doi.org/10.1016/j.cmet.2016.08.011
[4] Buenrostro, J. D., Wu, B., Litzenburger, U. M., et al. (2015). Single-cell chromatin accessibility reveals principles of regulatory variation. Nature, 523(7561), 486-490. https://doi.org/10.1038/nature14590
[5] Cabrita, R., Lauss, M., Sanna, A., et al. (2020). Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature, 577(7791), 561-565. https://doi.org/10.1038/s41586-019-1914-8
[6] Chen, Z., & Wang, J. H. (2019). Signaling control of antibody isotype switching. Adv Immunol, 141, 105-164. https://doi.org/10.1016/bs.ai.2019.01.001
[7] Colegio, O. R., Chu, N. Q., Szabo, A. L., et al. (2014). Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature, 513(7519), 559-563. https://doi.org/10.1038/nature13490
[8] Dai, X., Lv, X., Thompson, E. W., & Ostrikov, K. K. (2022). Histone lactylation: Epigenetic mark of glycolytic switch. Trends Genet, 38(2), 124-127. https://doi.org/10.1016/j.tig.2021.09.009
[9] Dieu-Nosjean, M. C., Antoine, M., Danel, C., et al. (2008). Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol, 26(27), 4410-4417. https://doi.org/10.1200/JCO.2007.15.0284
[10] Ersching, J., Efeyan, A., Mesin, L., Jacobsen, J. T., Pasqual, G., Grabiner, B. C., Dominguez-Sola, D., Sabatini, D. M., & Victora, G. D. (2017). Germinal center selection and affinity maturation require dynamic regulation of mTORC1 kinase. Immunity, 46(6), 1045-1058.e6. https://doi.org/10.1016/j.immuni.2017.06.005
[11] Fridman, W. H., Meylan, M., Petitprez, F., Sun, C. M., Italiano, A., & Sautès-Fridman, C. (2022). B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome. Nat Rev Clin Oncol, 19(7), 441-457. https://doi.org/10.1038/s41571-022-00619-z
[12] Germain, C., Gnjatic, S., Tamzalit, F., et al. (2014). Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med, 189(7), 832-844. https://doi.org/10.1164/rccm.201309-1611OC
[13] Helmink, B. A., Reddy, S. M., Gao, J., et al. (2020). B cells and tertiary lymphoid structures promote immunotherapy response. Nature, 577(7791), 549-555. https://doi.org/10.1038/s41586-019-1922-8
[14] Jellusova, J., & Rickert, R. C. (2016). The PI3K pathway in B cell metabolism. Crit Rev Biochem Mol Biol, 51(5), 359-378. https://doi.org/10.1080/10409238.2016.1215288
[15] Kaya-Okur, H. S., Wu, S. J., Codomo, C. A., et al. (2019). CUT & Tag for efficient epigenomic profiling of small samples and single cells. Nat Commun, 10(1), 1930. https://doi.org/10.1038/s41467-019-09982-5
[16] Laumont, C. M., Banville, A. C., Gilardi, M., Hollern, D. P., & Nelson, B. H. (2022). Tumour-infiltrating B cells: Immunological mechanisms, clinical impact and therapeutic opportunities. Nat Rev Cancer, 22(7), 414-430. https://doi.org/10.1038/s41568-022-00466-1
[17] Moreno-Yruela, C., Bæk, M., Monda, F., et al. (2022). Class I histone deacetylases (HDAC1–3) are histone lysine delactylases. Sci Adv, 8(3), eabi6696. https://doi.org/10.1126/sciadv.abi6696
[18] Pavri, R., Gazumyan, A., Jankovic, M., et al. (2010). Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell, 143(1), 122-133. https://doi.org/10.1016/j.cell.2010.09.017
[19] Petitprez, F., de Reyniès, A., Keung, E. Z., et al. (2020). B cells are associated with survival and immunotherapy response in sarcoma. Nature, 577(7791), 556-560. https://doi.org/10.1038/s41586-019-1906-8
[20] Stubbington, M. J. T., Rozenblatt-Rosen, O., Regev, A., & Teichmann, S. A. (2017). Single-cell transcriptomics to explore the immune system in health and disease. Science, 358(6359), 58-63. https://doi.org/10.1126/science.aan6828
[21] Wang, Z. H., Peng, W. B., Zhang, P., et al. (2021). Lactate in the tumour microenvironment: From immune modulation to therapy. EBioMedicine, 73, 103627. https://doi.org/10.1016/j.ebiom.2021.103627
[22] Warburg, O. (1956). On the origin of cancer cells. Science, 123(3191), 309-314. https://doi.org/10.1126/science.123.3191.309
[23] Yu, J., Chai, P., Xie, M., et al. (2021). Histone lactylation drives oncogenesis by facilitating m⁶A reader protein YTHDF2 expression in ocular melanoma. Genome Biol, 22(1), 85. https://doi.org/10.1186/s13059-021-02308-z
[24] Zhang, D., Tang, Z., Huang, H., et al. (2019). Metabolic regulation of gene expression by histone lactylation. Nature, 574(7779), 575-580. https://doi.org/10.1038/s41586-019-1678-1
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Gang Liu, Alena Mikalaeuna Vasiukevich, Jia Wang
This work is licensed under a Creative Commons Attribution 4.0 International License.